Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 132.40
Bid: 131.40
Ask: 132.40
Change: -4.60 (-3.36%)
Spread: 1.00 (0.761%)
Open: 134.60
High: 137.00
Low: 132.20
Prev. Close: 137.00
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Kier Group Plc

14 May 2013 14:48

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings are being disclosed: The Vanguard Group, Inc.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Kier Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: 13 May 2013
(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer? Yes, Costain Group Plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 1p Ordinary

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 630,673* 1.58%
(2) Derivatives (other than options):
(3) Options and agreements to purchase/sell:

TOTAL:

630,673* 1.58%

*Please note that The Vanguard Group, Inc. Does not have investment discretion over of 335,985 these shares.

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other executive options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
Common Stock Purchase 1,643 11.93

(b) Derivatives transactions (other than options)

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercising

Class of relevant security Product description

e.g. call option

Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 14 May 2013
Contact name: Nick Gould
Telephone number: 610-669-8989

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Copyright Business Wire 2013

Date   Source Headline
1st Nov 20213:17 pmRNSDirector/PDMR Shareholding
1st Nov 20219:38 amRNSTotal Voting Rights
29th Oct 202112:59 pmRNSDirector/PDMR Shareholding
26th Oct 20211:00 pmRNSDirector/PDMR Shareholding
19th Oct 20213:47 pmRNSDirector/PDMR Shareholding
19th Oct 202110:00 amRNSHolding(s) in Company
15th Oct 202111:43 amRNSAnnual Financial Report
5th Oct 202111:04 amRNSDirector/PDMR Shareholding
30th Sep 20219:33 amRNSHolding(s) in Company
21st Sep 20212:17 pmRNSDirector/PDMR Shareholding
20th Sep 20214:52 pmRNSHolding(s) in Company
16th Sep 20217:00 amRNSResults for the year ended 30 June 2021
9th Sep 202111:00 amRNSHolding(s) in Company
2nd Sep 202111:22 amRNSHolding(s) in Company
1st Sep 20218:52 amRNSTotal Voting Rights
31st Aug 20214:07 pmRNSHolding(s) in Company
23rd Aug 20211:05 pmRNSHolding(s) in Company
20th Aug 202110:27 amRNSDirector/PDMR Shareholding
2nd Aug 20219:27 amRNSTotal Voting Rights
23rd Jul 202111:46 amRNSDirector/PDMR Shareholding
23rd Jul 20219:36 amRNSHolding(s) in Company
13th Jul 20217:00 amRNSFull Year 2021 Trading Update
13th Jul 20217:00 amRNSFull Year 2021 Trading Update
1st Jul 20219:05 amRNSBlock listing Interim Review
1st Jul 20218:36 amRNSTotal Voting Rights
25th Jun 20214:41 pmRNSHolding(s) in Company
22nd Jun 20214:05 pmRNSHolding(s) in Company
21st Jun 20213:59 pmRNSDirector/PDMR Shareholding
21st Jun 20212:59 pmRNSHolding(s) in Company
18th Jun 20212:30 pmRNSDirector/PDMR Shareholding
18th Jun 20219:47 amRNSDirector/PDMR Shareholding
18th Jun 20218:30 amRNSHolding(s) in Company
18th Jun 20217:00 amRNSAdmission to trading and notice of trading update
17th Jun 20214:07 pmRNSHolding(s) in Company
16th Jun 202110:17 amRNSResult of Meeting
15th Jun 20218:11 amRNSResult of Open Offer
28th May 20212:56 pmRNSCompletion of the sale of Kier Living
14th May 20214:30 pmRNSDirector/PDMR Shareholding
13th May 20215:36 pmRNSPublication of Prospectus and Notice of GM
13th May 20213:34 pmRNSSuccessful completion of Accelerated Bookbuild
13th May 20217:00 amRNSProposed c.£241 million Capital Raise
7th May 202110:29 amRNSResult of Meeting
5th May 20217:00 amRNSExecutive Appointments
21st Apr 20217:00 amRNSResults for the six months ended 31 December 2020
20th Apr 20215:02 pmRNSNotice of GM
16th Apr 20215:01 pmRNSSale of Kier Living
12th Apr 202111:52 amRNSDirector/PDMR Shareholding
19th Mar 20213:07 pmRNSDirector/PDMR Shareholding
22nd Feb 20214:37 pmRNSDirector/PDMR Shareholding
16th Feb 20216:15 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.